Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $99,015 | 28 | 86.0% |
| Honoraria | $8,700 | 1 | 7.6% |
| Travel and Lodging | $6,144 | 23 | 5.3% |
| Food and Beverage | $1,251 | 23 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $20,415 | 22 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $16,004 | 12 | $0 (2022) |
| GW Pharma Limited | $12,684 | 4 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $12,125 | 3 | $0 (2022) |
| Boehringer Ingelheim International GmbH | $11,250 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,350 | 6 | $0 (2023) |
| H. Lundbeck A S | $8,700 | 1 | $0 (2023) |
| Alkermes, Inc. | $8,037 | 7 | $0 (2018) |
| Braeburn Pharmaceuticals, Inc. | $6,398 | 9 | $0 (2017) |
| Biogen, Inc. | $4,209 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,063 | 3 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($937.50) |
| 2023 | $23,259 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,350) |
| 2022 | $21,250 | 6 | ACADIA Pharmaceuticals Inc ($8,500) |
| 2021 | $13,125 | 5 | JAZZ PHARMACEUTICALS INC. ($5,000) |
| 2020 | $16,309 | 5 | GW Pharma Limited ($12,684) |
| 2019 | $24,669 | 31 | Janssen Research & Development, LLC ($18,665) |
| 2018 | $8,037 | 7 | Alkermes, Inc. ($8,037) |
| 2017 | $6,398 | 9 | Braeburn Pharmaceuticals, Inc. ($6,398) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 04/09/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $937.50 | General |
| Category: PSYCHIATRY | ||||||
| 01/26/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 12/21/2023 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 06/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 06/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.00 | General |
| 06/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 05/18/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,208.50 | General |
| 05/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $44.14 | General |
| 03/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $1,319.13 | General |
| 03/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $312.17 | General |
| 01/20/2023 | H. Lundbeck A S | — | Honoraria | Cash or cash equivalent | $8,700.00 | General |
| 06/30/2022 | Sumitomo Pharma Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 06/14/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/27/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/26/2022 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 03/23/2022 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 03/04/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: NEUROLOGY | ||||||
| 11/24/2021 | Eisai Inc. | Dayvigo (Drug) | Consulting Fee | Cash or cash equivalent | $3,625.00 | General |
| Category: Neurology | ||||||
| 08/05/2021 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 05/28/2021 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 04/05/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 02/02/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 11/24/2020 | GW Pharma Limited | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurology | ||||||
| 08/25/2020 | GW Pharma Limited | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 24 | $8,856 | $2,415 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 24 | $8,856 | $2,415 | 27.3% |
About Murray Stein, M.D., M.P.H
Murray Stein, M.D., M.P.H is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659390771.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Murray Stein, M.D., M.P.H has received a total of $115,110 in payments from pharmaceutical and medical device companies, with $2,063 received in 2024. These payments were reported across 75 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($99,015).
As a Medicare-enrolled provider, Stein has provided services to 17 Medicare beneficiaries, totaling 24 services with total Medicare billing of $2,415. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location San Diego, CA
- Active Since 07/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659390771
Products in Payments
- NUPLAZID (Drug) $12,125
- Epidiolex (Drug) $9,434
- XYREM (Drug) $6,004
- XYWAV (Drug) $5,000
- Dayvigo (Drug) $3,625
- CAM2038 $952.46
- REXULTI (Drug) $937.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Jonathan Meyer, M.d, M.D
Psychiatry — Payments: $2.0M
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261
Dr. Vishaal Mehra, Md, MD
Psychiatry — Payments: $56,945